Calcium glycerophosphate, ergocalciferol, ferric ammonium, potassium glycerophosphate, retinol palmitate, sodium glycerophosphate
Sold as Minadex
Every registration of this product has been cancelled.
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
Background
Registration
- Applicants
- 1
- Registrations
- 1
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Glaxo-allenburys (Pty) LtdCancelled | Minadex | Not stated | G2570 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Minadex EACH 5 ML SYRUP CONTAINS CALCIUM GLYCEROPHOSPHATE A 15 MG ERGOCALCIFEROL A 0,16 MG FERRIC AMMONIUM CITRATE A 170 MG POTASSIUM GLYCEROPHOSPHATE A 2,5 MG RETINOL PALMITATE A 4125 UNITS SODIUM GLYCEROPHOSPHATE A 1,0 MG | Not listed | G2570 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.